£495.00

The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies in China

Price data last checked 46 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£495 today · cheaper than every other day in the last 2 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 1 days • 1 data points (No recent data available)

Historical
Generating forecast...
Not enough data points to display chart (need at least 2 points)

Price Distribution

Price distribution over 1 days • 1 price levels

Days at Price
1 day 0 0 1 1 1 £495 Days at Price

Price Analysis

Most common price: £495 (1 days, 100.0%)

Price range: £495 - £495

Price levels: 1 different prices over 1 days

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
16 August 2022
Listed Since
24 August 2022

Similar Products You Might Like

The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatments in China
99% match

The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatments in China

£495.00 13 Dec 2025
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies in Japan
99% match

The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies in Japan

£495.00 24 Jan 2026
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatments in Japan
99% match

The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatments in Japan

£495.00 12 Jan 2026
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies for US Zip Codes
99% match

The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies for US Zip Codes

£490.00 13 Apr 2026
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies in the United States
99% match

The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies in the United States

£520.00 07 Feb 2026
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies in India
99% match

The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies in India

£515.00 08 Feb 2026
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatments in India
99% match

The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatments in India

£515.00 06 Feb 2026
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatments for US Zip Codes
99% match

The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatments for US Zip Codes

£490.00 25 Jan 2026
The 2025-2030 World Outlook for Alpha-1 Antitrypsin Deficiency Treatments
99% match

The 2025-2030 World Outlook for Alpha-1 Antitrypsin Deficiency Treatments

£790.00 01 Feb 2026
The 2026-2031 World Outlook for Alpha-1 Antitrypsin Deficiency Treatments
98% match

The 2026-2031 World Outlook for Alpha-1 Antitrypsin Deficiency Treatments

£885.00 31 Jan 2026
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatments in the United States
98% match

The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatments in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Alpha-1 Antitrypsin Drugs for US Zip Codes
98% match

The 2023-2028 Outlook for Alpha-1 Antitrypsin Drugs for US Zip Codes

£490.00 30 Jan 2026
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in China
96% match

The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in China

£495.00 31 Jan 2026
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in China
95% match

The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in China

£495.00 20 Jan 2026
The 2013-2018 Outlook for Air Treatment Products in India
95% match

The 2013-2018 Outlook for Air Treatment Products in India

£495.00 07 Jan 2026
The 2023-2028 Outlook for Air Treatment Products in Japan
95% match

The 2023-2028 Outlook for Air Treatment Products in Japan

£495.00 10 Mar 2026
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments for US Zip Codes
95% match

The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments for US Zip Codes

£490.00 01 Feb 2026
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in Japan
95% match

The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in Japan

£495.00 05 Feb 2026
The 2023-2028 Outlook for Anti-Inflammatory Asthma Drugs in China
95% match

The 2023-2028 Outlook for Anti-Inflammatory Asthma Drugs in China

£495.00 24 Jan 2026
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in India
95% match

The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in India

£515.00 05 Feb 2026
The 2023-2028 Outlook for Animal Health Active Pharmaceutical Ingredients in China
95% match

The 2023-2028 Outlook for Animal Health Active Pharmaceutical Ingredients in China

£495.00 08 Jan 2026
The 2013-2018 Outlook for Bronchial Dilator and Anti-Asthmatic Pharmaceutical Preparations in India
95% match

The 2013-2018 Outlook for Bronchial Dilator and Anti-Asthmatic Pharmaceutical Preparations in India

£495.00 31 Jan 2026
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments for US Zip Codes
95% match

The 2023-2028 Outlook for Pulmonary Fibrosis Treatments for US Zip Codes

£490.00 30 Jan 2026
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in the United States
95% match

The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in the United States

£520.00 13 Jan 2026